A new vaccine against salmonella and typhoid moves closer to approval, according to results of a clinical trial published by researchers at the University of Maryland School of Medicine Oct. 8. “These ...

Add Yahoo as a preferred source to see more of our stories on Google. Typhoid fever, an illness that has been controlled in developed countries since the early 20th century, is evolving to be ...

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj. ® Multi-dose is manufactured ...

Baltimore, MD — October 8, 2025 — Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical ...

Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people ...

Vaccine programs are being challenged by rising misinformation and an uncertain pipeline for research funding, the World Health Organization's immunization experts said Wednesday.

The recipients were Prof. Samuel Garba of Federal University of Technology, Minna, who developed typhoid vaccine and Dr Ololade Olatunji of University of Lagos, who developed micro-needles from fish ...

In a landmark public health initiative, Bangladesh launched a nationwide Typhoid Conjugate Vaccine (TCV) campaign in October 2025. With support from WHO, UNICEF, Gavi (the Vaccine Alliance), and other ...

Typhoid fever, an illness that has been controlled in developed countries since the early 20th century, is evolving to be antibiotic-resistant. Research published in 2022 shows that typhoid is ...